Vivek Ramaswamy

News

Vivek Ramaswamy exits presidential race after Iowa result

Biotech entrepreneur Vivek Ramaswamy’s campaign to become the Republican candidate for the US presidency in the 2024 election has been suspended after a disappointing resu

News

Vivek Ramaswamy confirms bid for US presidency

Biotech entrepreneur has launched his Vivek2024 campaign with an attack on the 'woke left'.

News

Enzyvant gains double fast-track for rare disease drug

Switzerland-based biopharma start-up Enzyvant has gained a double fast track status from the FDA for its new rare disease candidate RVT-802.

Vivek Ramaswamy exits presidential race after Iowa result

Vivek Ramaswamy confirms bid for US presidency

Enzyvant gains double fast-track for rare disease drug

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks